Do analysts recommend SKYA or FOCL?

FocalTherics has a consensus price target of $9.00, suggesting a potential upside of 44.00%. Given FocalTherics' stronger consensus rating and higher probable upside, analysts plainly believe FocalTherics is more favorable than SkyAI, Inc. Common Stock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SkyAI, Inc. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 FocalTherics 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50

Do analysts prefer EMBC or SKYA?

Embecta currently has a consensus price target of $11.00, indicating a potential upside of 198.91%. Given Embecta's stronger consensus rating and higher probable upside, equities analysts plainly believe Embecta is more favorable than SkyAI, Inc. Common Stock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Embecta 2 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.60 SkyAI, Inc. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor EMBC or SKYA?

In the previous week, Embecta had 35 more articles in the media than SkyAI, Inc. Common Stock. MarketBeat recorded 39 mentions for Embecta and 4 mentions for SkyAI, Inc. Common Stock. SkyAI, Inc. Common Stock's average media sentiment score of 1.09 beat Embecta's score of 0.05 indicating that SkyAI, Inc. Common Stock is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Embecta 1 Very Positive mention(s) 0 Positive mention(s) 37 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SkyAI, Inc. Common Stock 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer SKYA or LUCD?

Lucid Diagnostics has a consensus target price of $4.19, indicating a potential upside of 355.86%. Given Lucid Diagnostics' stronger consensus rating and higher probable upside, analysts plainly believe Lucid Diagnostics is more favorable than SkyAI, Inc. Common Stock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SkyAI, Inc. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Lucid Diagnostics 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60

Does the media prefer SKYA or LUCD?

In the previous week, SkyAI, Inc. Common Stock had 2 more articles in the media than Lucid Diagnostics. MarketBeat recorded 4 mentions for SkyAI, Inc. Common Stock and 2 mentions for Lucid Diagnostics. SkyAI, Inc. Common Stock's average media sentiment score of 1.09 beat Lucid Diagnostics' score of 0.83 indicating that SkyAI, Inc. Common Stock is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SkyAI, Inc. Common Stock 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Lucid Diagnostics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer SKYA or KRMD?

KORU Medical Systems has a consensus price target of $7.25, indicating a potential upside of 78.13%. Given KORU Medical Systems' stronger consensus rating and higher possible upside, analysts clearly believe KORU Medical Systems is more favorable than SkyAI, Inc. Common Stock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SkyAI, Inc. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 KORU Medical Systems 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60

Does the media prefer SKYA or KRMD?

In the previous week, SkyAI, Inc. Common Stock and SkyAI, Inc. Common Stock both had 4 articles in the media. SkyAI, Inc. Common Stock's average media sentiment score of 1.09 beat KORU Medical Systems' score of 0.69 indicating that SkyAI, Inc. Common Stock is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SkyAI, Inc. Common Stock 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive KORU Medical Systems 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer INFU or SKYA?

InfuSystem currently has a consensus target price of $15.00, indicating a potential upside of 53.69%. Given InfuSystem's stronger consensus rating and higher probable upside, equities research analysts plainly believe InfuSystem is more favorable than SkyAI, Inc. Common Stock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InfuSystem 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 SkyAI, Inc. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor INFU or SKYA?

In the previous week, SkyAI, Inc. Common Stock had 3 more articles in the media than InfuSystem. MarketBeat recorded 4 mentions for SkyAI, Inc. Common Stock and 1 mentions for InfuSystem. SkyAI, Inc. Common Stock's average media sentiment score of 1.09 beat InfuSystem's score of 0.00 indicating that SkyAI, Inc. Common Stock is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InfuSystem 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SkyAI, Inc. Common Stock 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

SkyAI, Inc. Common Stock (SKYA) Competitors

$1.37 -0.03 (-2.14%)

As of 07/29/2026 04:00 PM Eastern

Compare

SKYA vs. FOCL, EMBC, LUCD, KRMD, and INFU

Should you buy SkyAI, Inc. Common Stock stock or one of its competitors? MarketBeat compares SkyAI, Inc. Common Stock with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with SkyAI, Inc. Common Stock include FocalTherics (FOCL), Embecta (EMBC), Lucid Diagnostics (LUCD), KORU Medical Systems (KRMD), and InfuSystem (INFU). These companies are all part of the "medical equipment" industry.

How does SkyAI, Inc. Common Stock compare to FocalTherics?

SkyAI, Inc. Common Stock (NASDAQ:SKYA) and FocalTherics (NASDAQ:FOCL) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation.

FocalTherics has a consensus price target of $9.00, suggesting a potential upside of 44.00%. Given FocalTherics' stronger consensus rating and higher probable upside, analysts plainly believe FocalTherics is more favorable than SkyAI, Inc. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SkyAI, Inc. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
FocalTherics	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

SkyAI, Inc. Common Stock has a net margin of 0.00% compared to FocalTherics' net margin of -41.47%. FocalTherics' return on equity of -137.61% beat SkyAI, Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SkyAI, Inc. Common Stock	N/A	-157.91%	-154.40%
FocalTherics	-41.47%	-137.61%	-40.62%

17.2% of SkyAI, Inc. Common Stock shares are held by institutional investors. Comparatively, 62.7% of FocalTherics shares are held by institutional investors. 20.0% of SkyAI, Inc. Common Stock shares are held by insiders. Comparatively, 10.1% of FocalTherics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

FocalTherics has higher revenue and earnings than SkyAI, Inc. Common Stock. FocalTherics is trading at a lower price-to-earnings ratio than SkyAI, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SkyAI, Inc. Common Stock	$200K	289.89	-$282.50M	-$1.63	N/A
FocalTherics	$70.53M	3.32	-$29.25M	-$0.81	N/A

In the previous week, SkyAI, Inc. Common Stock had 3 more articles in the media than FocalTherics. MarketBeat recorded 4 mentions for SkyAI, Inc. Common Stock and 1 mentions for FocalTherics. FocalTherics' average media sentiment score of 1.89 beat SkyAI, Inc. Common Stock's score of 1.09 indicating that FocalTherics is being referred to more favorably in the news media.

Company	Overall Sentiment
SkyAI, Inc. Common Stock	Positive
FocalTherics	Very Positive

SkyAI, Inc. Common Stock has a beta of 2.1, suggesting that its share price is 110% more volatile than the broader market. Comparatively, FocalTherics has a beta of -0.04, suggesting that its share price is 104% less volatile than the broader market.

Summary

FocalTherics beats SkyAI, Inc. Common Stock on 11 of the 17 factors compared between the two stocks.

How does SkyAI, Inc. Common Stock compare to Embecta?

Embecta (NASDAQ:EMBC) and SkyAI, Inc. Common Stock (NASDAQ:SKYA) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation.

93.8% of Embecta shares are held by institutional investors. Comparatively, 17.2% of SkyAI, Inc. Common Stock shares are held by institutional investors. 1.3% of Embecta shares are held by company insiders. Comparatively, 20.0% of SkyAI, Inc. Common Stock shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Embecta has higher revenue and earnings than SkyAI, Inc. Common Stock. SkyAI, Inc. Common Stock is trading at a lower price-to-earnings ratio than Embecta, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Embecta	$1.08B	0.20	$95.40M	$1.90	1.94
SkyAI, Inc. Common Stock	$200K	289.89	-$282.50M	-$1.63	N/A

Embecta has a beta of 0.83, meaning that its share price is 17% less volatile than the broader market. Comparatively, SkyAI, Inc. Common Stock has a beta of 2.1, meaning that its share price is 110% more volatile than the broader market.

Embecta has a net margin of 10.73% compared to SkyAI, Inc. Common Stock's net margin of 0.00%. Embecta's return on equity of -23.96% beat SkyAI, Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Embecta	10.73%	-23.96%	14.12%
SkyAI, Inc. Common Stock	N/A	-157.91%	-154.40%

Embecta currently has a consensus price target of $11.00, indicating a potential upside of 198.91%. Given Embecta's stronger consensus rating and higher probable upside, equities analysts plainly believe Embecta is more favorable than SkyAI, Inc. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Embecta	2 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.60
SkyAI, Inc. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Embecta had 35 more articles in the media than SkyAI, Inc. Common Stock. MarketBeat recorded 39 mentions for Embecta and 4 mentions for SkyAI, Inc. Common Stock. SkyAI, Inc. Common Stock's average media sentiment score of 1.09 beat Embecta's score of 0.05 indicating that SkyAI, Inc. Common Stock is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Embecta	1 Very Positive mention(s)	0 Positive mention(s)	37 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
SkyAI, Inc. Common Stock	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Embecta beats SkyAI, Inc. Common Stock on 11 of the 15 factors compared between the two stocks.

How does SkyAI, Inc. Common Stock compare to Lucid Diagnostics?

SkyAI, Inc. Common Stock (NASDAQ:SKYA) and Lucid Diagnostics (NASDAQ:LUCD) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, media sentiment, earnings, risk and valuation.

In the previous week, SkyAI, Inc. Common Stock had 2 more articles in the media than Lucid Diagnostics. MarketBeat recorded 4 mentions for SkyAI, Inc. Common Stock and 2 mentions for Lucid Diagnostics. SkyAI, Inc. Common Stock's average media sentiment score of 1.09 beat Lucid Diagnostics' score of 0.83 indicating that SkyAI, Inc. Common Stock is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SkyAI, Inc. Common Stock	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Lucid Diagnostics	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Lucid Diagnostics has higher revenue and earnings than SkyAI, Inc. Common Stock. Lucid Diagnostics is trading at a lower price-to-earnings ratio than SkyAI, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SkyAI, Inc. Common Stock	$200K	289.89	-$282.50M	-$1.63	N/A
Lucid Diagnostics	$4.71M	39.61	-$58.01M	-$0.47	N/A

17.2% of SkyAI, Inc. Common Stock shares are owned by institutional investors. Comparatively, 74.0% of Lucid Diagnostics shares are owned by institutional investors. 20.0% of SkyAI, Inc. Common Stock shares are owned by company insiders. Comparatively, 6.9% of Lucid Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

SkyAI, Inc. Common Stock has a net margin of 0.00% compared to Lucid Diagnostics' net margin of -876.72%. Lucid Diagnostics' return on equity of 0.00% beat SkyAI, Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SkyAI, Inc. Common Stock	N/A	-157.91%	-154.40%
Lucid Diagnostics	-876.72%	N/A	-116.26%

SkyAI, Inc. Common Stock has a beta of 2.1, suggesting that its share price is 110% more volatile than the broader market. Comparatively, Lucid Diagnostics has a beta of 1.07, suggesting that its share price is 7% more volatile than the broader market.

Lucid Diagnostics has a consensus target price of $4.19, indicating a potential upside of 355.86%. Given Lucid Diagnostics' stronger consensus rating and higher probable upside, analysts plainly believe Lucid Diagnostics is more favorable than SkyAI, Inc. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SkyAI, Inc. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Lucid Diagnostics	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Summary

Lucid Diagnostics beats SkyAI, Inc. Common Stock on 9 of the 16 factors compared between the two stocks.

How does SkyAI, Inc. Common Stock compare to KORU Medical Systems?

SkyAI, Inc. Common Stock (NASDAQ:SKYA) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation.

KORU Medical Systems has a consensus price target of $7.25, indicating a potential upside of 78.13%. Given KORU Medical Systems' stronger consensus rating and higher possible upside, analysts clearly believe KORU Medical Systems is more favorable than SkyAI, Inc. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SkyAI, Inc. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

KORU Medical Systems has higher revenue and earnings than SkyAI, Inc. Common Stock. KORU Medical Systems is trading at a lower price-to-earnings ratio than SkyAI, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SkyAI, Inc. Common Stock	$200K	289.89	-$282.50M	-$1.63	N/A
KORU Medical Systems	$41.13M	4.54	-$2.64M	-$0.05	N/A

SkyAI, Inc. Common Stock has a net margin of 0.00% compared to KORU Medical Systems' net margin of -5.27%. KORU Medical Systems' return on equity of -13.61% beat SkyAI, Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SkyAI, Inc. Common Stock	N/A	-157.91%	-154.40%
KORU Medical Systems	-5.27%	-13.61%	-8.33%

17.2% of SkyAI, Inc. Common Stock shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 20.0% of SkyAI, Inc. Common Stock shares are owned by company insiders. Comparatively, 18.5% of KORU Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, SkyAI, Inc. Common Stock and SkyAI, Inc. Common Stock both had 4 articles in the media. SkyAI, Inc. Common Stock's average media sentiment score of 1.09 beat KORU Medical Systems' score of 0.69 indicating that SkyAI, Inc. Common Stock is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SkyAI, Inc. Common Stock	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
KORU Medical Systems	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

SkyAI, Inc. Common Stock has a beta of 2.1, suggesting that its share price is 110% more volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.41, suggesting that its share price is 59% less volatile than the broader market.

Summary

KORU Medical Systems beats SkyAI, Inc. Common Stock on 9 of the 15 factors compared between the two stocks.

How does SkyAI, Inc. Common Stock compare to InfuSystem?

InfuSystem (NYSE:INFU) and SkyAI, Inc. Common Stock (NASDAQ:SKYA) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends, media sentiment and earnings.

InfuSystem currently has a consensus target price of $15.00, indicating a potential upside of 53.69%. Given InfuSystem's stronger consensus rating and higher probable upside, equities research analysts plainly believe InfuSystem is more favorable than SkyAI, Inc. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InfuSystem	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
SkyAI, Inc. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

InfuSystem has higher revenue and earnings than SkyAI, Inc. Common Stock. SkyAI, Inc. Common Stock is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InfuSystem	$142.40M	1.38	$870K	$0.38	25.68
SkyAI, Inc. Common Stock	$200K	289.89	-$282.50M	-$1.63	N/A

In the previous week, SkyAI, Inc. Common Stock had 3 more articles in the media than InfuSystem. MarketBeat recorded 4 mentions for SkyAI, Inc. Common Stock and 1 mentions for InfuSystem. SkyAI, Inc. Common Stock's average media sentiment score of 1.09 beat InfuSystem's score of 0.00 indicating that SkyAI, Inc. Common Stock is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InfuSystem	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
SkyAI, Inc. Common Stock	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

71.1% of InfuSystem shares are owned by institutional investors. Comparatively, 17.2% of SkyAI, Inc. Common Stock shares are owned by institutional investors. 10.8% of InfuSystem shares are owned by insiders. Comparatively, 20.0% of SkyAI, Inc. Common Stock shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

InfuSystem has a beta of 1.4, suggesting that its stock price is 40% more volatile than the broader market. Comparatively, SkyAI, Inc. Common Stock has a beta of 2.1, suggesting that its stock price is 110% more volatile than the broader market.

InfuSystem has a net margin of 1.12% compared to SkyAI, Inc. Common Stock's net margin of 0.00%. InfuSystem's return on equity of 2.78% beat SkyAI, Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InfuSystem	1.12%	2.78%	1.41%
SkyAI, Inc. Common Stock	N/A	-157.91%	-154.40%

Summary

InfuSystem beats SkyAI, Inc. Common Stock on 11 of the 16 factors compared between the two stocks.

Get SkyAI, Inc. Common Stock News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SKYA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SKYA vs. The Competition

Export

Metric	SkyAI, Inc. Common Stock	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$59.25M	$9.25B	$7.08B	$12.15B
Dividend Yield	N/A	2.54%	2.65%	8.53%
P/E Ratio	-0.84	19.40	27.40	23.33
Price / Sales	289.89	7.04	521.07	86.08
Price / Cash	N/A	18.73	51.57	59.34
Price / Book	0.15	3.33	10.06	5.74
Net Income	-$282.50M	$235.78M	$3.60B	$336.32M
7 Day Performance	-4.20%	-0.25%	-1.40%	-1.96%
1 Month Performance	23.42%	-3.16%	-4.38%	-6.16%
1 Year Performance	-72.60%	-1.94%	20.26%	13.66%

SkyAI, Inc. Common Stock Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SKYA SkyAI, Inc. Common Stock	0.6005 of 5 stars	$1.37 -2.1%	N/A	-75.7%	$59.25M	$200K	N/A	55	Positive News Short Interest Increase
FOCL FocalTherics	3.7402 of 5 stars	$5.68 +1.2%	$9.00 +58.5%	N/A	$210.27M	$70.53M	N/A	230	Positive News
EMBC Embecta	4.4039 of 5 stars	$3.37 -2.0%	$11.00 +226.4%	-65.8%	$204.09M	$1.08B	1.77	1,850	Trending News
LUCD Lucid Diagnostics	3.4339 of 5 stars	$0.97 -0.3%	$4.19 +333.2%	-14.9%	$196.83M	$4.71M	N/A	70
KRMD KORU Medical Systems	3.5166 of 5 stars	$4.03 -0.7%	$7.25 +79.9%	+17.0%	$186.49M	$43.26M	N/A	80	News Coverage Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SKYA) was last updated on 7/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SkyAI, Inc. Common Stock (SKYA) Competitors

SKYA vs. FOCL, EMBC, LUCD, KRMD, and INFU

How does SkyAI, Inc. Common Stock compare to FocalTherics?

Summary

How does SkyAI, Inc. Common Stock compare to Embecta?

Summary

How does SkyAI, Inc. Common Stock compare to Lucid Diagnostics?

Summary

How does SkyAI, Inc. Common Stock compare to KORU Medical Systems?

Summary

How does SkyAI, Inc. Common Stock compare to InfuSystem?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SKYA vs. The Competition

SkyAI, Inc. Common Stock Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

SkyAI, Inc. Common Stock (SKYA) Competitors

SKYA vs. FOCL, EMBC, LUCD, KRMD, and INFU

How does SkyAI, Inc. Common Stock compare to FocalTherics?

Do analysts recommend SKYA or FOCL?

Is SKYA or FOCL more profitable?

Do insiders & institutionals believe in SKYA or FOCL?

Which has better earnings & valuation, SKYA or FOCL?

Does the media prefer SKYA or FOCL?

Which has more volatility & risk, SKYA or FOCL?

Summary

How does SkyAI, Inc. Common Stock compare to Embecta?

Do institutionals & insiders have more ownership in EMBC or SKYA?

Which has better valuation and earnings, EMBC or SKYA?

Which has more risk & volatility, EMBC or SKYA?

Is EMBC or SKYA more profitable?

Do analysts prefer EMBC or SKYA?

Does the media favor EMBC or SKYA?

Summary

How does SkyAI, Inc. Common Stock compare to Lucid Diagnostics?

Does the media prefer SKYA or LUCD?

Which has stronger earnings & valuation, SKYA or LUCD?

Do institutionals and insiders believe in SKYA or LUCD?

Is SKYA or LUCD more profitable?

Which has more volatility & risk, SKYA or LUCD?

Do analysts prefer SKYA or LUCD?

Summary

How does SkyAI, Inc. Common Stock compare to KORU Medical Systems?

Do analysts prefer SKYA or KRMD?

Which has better valuation & earnings, SKYA or KRMD?

Is SKYA or KRMD more profitable?

Do insiders and institutionals believe in SKYA or KRMD?

Does the media prefer SKYA or KRMD?

Which has more volatility and risk, SKYA or KRMD?

Summary

How does SkyAI, Inc. Common Stock compare to InfuSystem?

Do analysts prefer INFU or SKYA?

Which has higher earnings and valuation, INFU or SKYA?

Does the media favor INFU or SKYA?

Do insiders & institutionals believe in INFU or SKYA?

Which has more risk & volatility, INFU or SKYA?

Is INFU or SKYA more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SKYA vs. The Competition

SkyAI, Inc. Common Stock Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools